Screener
Immix Biopharma, Inc. IMMX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
| Line item | 2026 / For the Three Months Ended / March 31, | 2025 / For the Three Months Ended / March 31, |
|---|---|---|
| Payments of deferred offering costs | (71,093) | - |
| Net cash provided by financing activities | (37,561) | - |
| Effect of foreign currency on cash | (12,813) | (8,000) |
| Net change in cash and cash equivalents | (14,678,403) | (1,760,853) |
| Cash and cash equivalents – beginning of period | 93,928,566 | 17,681,954 |
| Cash and cash equivalents – end of period | $79,250,163 | $15,921,101 |
| Supplemental Disclosures of Cash Flow Information: | ||
| Income taxes paid | - | $9,822 |
Document
FAQ
- What is Immix Biopharma, Inc.'s net change in cash?
- Immix Biopharma, Inc. (IMMX) reported net change in cash of -$14.68M in Q1 2026.
- How has Immix Biopharma, Inc.'s net change in cash changed year-over-year?
- Immix Biopharma, Inc.'s net change in cash decreased by 733.6% year-over-year, from -$1.76M to -$14.68M.
- What is the long-term trend for Immix Biopharma, Inc.'s net change in cash?
- Over 2 years (2021 to 2025), Immix Biopharma, Inc.'s net change in cash has grown at a 110.2% compound annual growth rate (CAGR), from $17.25M to $76.25M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Immix Biopharma, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude